Wilmington, DE, United States of America

Andrew Maynard

This inventor holds 2 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Other. Active years: 2004-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Maynard. Retrieved from https://idiyas.com/inventor/andrew-maynard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andrew Maynard

Introduction

Andrew Maynard is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thiolesters. With a total of 2 patents, Maynard's inventions have the potential to impact various applications in medicine.

Latest Patents

One of Andrew Maynard's latest patents is titled "Thiolesters and uses thereof." This invention pertains to the discovery of a novel family of thiolesters and their various applications. The patent also includes the development of viricidal compounds and pharmaceutical formulations that incorporate these novel thiolesters. Additionally, the invention provides for thiolester-inactivated viruses and thiolester-complexed viral proteins, showcasing the versatility and potential of his discoveries.

Career Highlights

Throughout his career, Andrew Maynard has worked with notable organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Andrew Maynard's coworkers include James A. Turpin and Yongsheng Song. Their collaborative efforts have likely enhanced the quality and impact of his research.

Conclusion

Andrew Maynard's innovative work in the field of thiolesters demonstrates his commitment to advancing pharmaceutical science. His patents and collaborations reflect a dedication to improving health outcomes through scientific discovery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…